Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results, page-31

fattchoi posted on the IMU CHARTS thread something, that does not belong on THAT thread but was very interesting....

fattchoi: "For example .... a Chinese BP approached IMUGENE....."

As the GASTRIC CANCER variety is so DOMINANT in Eastern Asia, I would think that the likelihood (besides the Chinese BP you did mention) that either a JAPANESE or SOUTH KOREAN BIG PHARMA company will indeed be VERY interested just for "only" their specific market (or regionally, of course) to enter into a deal with Imugene. Such a potential move might SPARK the two big contenders into action...

The worldwide game will (JIMHO) most likely be a fight between MERCK and ROCHE to protect their business models with Keytruda or Herceptin respectively. As long as one of those two will INDEED PAY a really, really MASSIVE take-over pricing, then all should be fine for us IMU holders and buyers.

More patience will be needed - most likely the most difficult thing for many here....

All the aforementioned as usual IMHO - and as so often, I could be wrong.

wasa